Cost savings through generic cardiovascular pharmaceuticals U.S. 2013| Statista

This statistic displays the cost savings in the United States associated with using generic cardiovascular pharmaceuticals from 2004 to 2013. In 2004, over 18.1 billion U.S. dollars were saved due to generic medication in the cardiovascular therapy area. Over the last decade, 1.46 trillion U.S. dollars were saved through the use of generic pharmaceuticals.

Cost savings through cardiovascular generic medicine in the United States from 2004 to 2013 (in million U.S. dollars)

Characteristic	Cost savings in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

October 2014

More information

Region

United States

Survey time period

2004 to 2013

Citation formats

Access all statistics starting from $2,388 USD yearly ^*

* For commercial use only

For single users

$0 USD

Always free

Access limited to Free Statistics. Premium Statistics are not included.

Free Statistics

Based on your interests

For single users

$199 USD

per month, billed annually ¹

Buy now

Free Statistics
Premium Statistics

The statistic on this page is a Premium Statistic and is included in this account.

For teams of up to 5 people

$1,299 USD

per month, billed annually ¹

Buy now

Free + Premium Statistics
Reports
Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Leading companies trust Statista:

Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.

Marlene Greenfield
Vice President, Hearst Magazines